Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 2, 1999, Pages 1169-1175

  Furlan, Valerie ^a   Demirdjian, Sylvie ^a   Bourdon, Oliver ^a   Magdalou, Jacques ^b   Taburet, Anne Marie ^a,c  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Clinical Pharmacy   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE; LAMOTRIGINE; LIDOCAINE; OXAZEPAM; UMBELLIFERONE; ZIDOVUDINE;

ADOLESCENT; ADULT; CELL TRANSFORMATION; CHILD; CONFERENCE PAPER; DRUG GLUCURONIDATION; DRUG METABOLISM; ENZYME BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LIVER CIRRHOSIS; LIVER MICROSOME; PREDICTION; PRIORITY JOURNAL; REACTION ANALYSIS;

ADOLESCENT; ADULT; AGING; ARYL HYDROCARBON HYDROXYLASES; BIOTRANSFORMATION; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HEPATITIS; HUMANS; LIVER CIRRHOSIS; MICROSOMES, LIVER; OXAZEPAM; OXIDOREDUCTASES, N-DEMETHYLATING; TRIAZINES; UMBELLIFERONES; XENOBIOTICS; ZIDOVUDINE;

EID: 0032937925     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Bargetzi MJ, Aoyama T, Gonzalez FJ and Meyer UA (1989) Lidocaine metabolism in human liver microsomes by cytochrome P450 III A4. Clin Pharmacol Ther 46:521-557.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of micrograms quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Coffman BL, King CD, Rios GR and Tephly TR (1998) The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y (268) and UGT2B7H (268). Drug Metab Dispos 26:73-77.
4. Colli A, Buccino G, Cocciolo M, Paravicini R and Scaltrini G (1988) Disposition of a flow-limited drug (lidocaine) and a metabolic capacity-limited drug (theophylline) in liver cirrhosis. Clin Pharmacol Ther 44:602-670.
5. Collins JM and Unadkat SD (1989) Clinical pharmacokinetics of zidovudine: An overview of current data. Clin Pharmacokinet 17:1-9.
6. De Bony F, Bidault R and Altman C (1997) Lamotrigine in subjects with liver cirrhosis [PII76]. Clin Pharmacol Ther 61:184.
7. De Vries MH, Hofman GA, Koster ASJ and Noordhoek J (1989) Systemic intestinal metabolism of 1-naphtol. Drug Metab Dispos 17:573-578.
8. Dowd JE and Riggs DS (1965) A comparison of estimates of Michaelis-Menten kinetic constants from various linear transformations. J Biol Chem 240:863-869.
9. Dragacci S, Thomassin J, Magdalou J, Souhaili EL, Amri H, Boissel P and Siest G (1987) Properties of human hepatic UDP-glucuronosyltransferases. Relationship to other inducible enzymes in patients with cholestasis. Eur J Clin Pharmacol 32:485-491.
10. Ebner T and Burchell B (1993) Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. Drug Metab Dispos 21: 50-57.
11. Fournel-Gigleux S, Sutherland L, Sabolovic N, Burchell B and Siest G (1990) Stable expression of two UDP-glucuronosyltransferase cDNA in V79 cell culture. Mol Pharmacol 39:177-183.
12. George J, Murray M, Byth K and Farrel GC (1995) Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology 21:120-128.
13. Good S, Koble CS, Crouch R, Johnson RL, Rideout JL and Miranda P (1990) Isolation and characterization of on ether glucuronide of zidovudine, a major metabolite on monkeys and humans. Drug Metab Dispos 18:321-326.
14. Green MD, Bishop WP and Tephly TR (1995) Expressed human UGT1.4 protein catalyses the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos 23:299-301.
15. Greenblat DJ (1981) Clinical pharmacokinetics of oxazepam and lorazepam. Clin Pharmacokinet 89:89-105.
16. Haumont M, Magdalou J, Lafaurie C, Ziegler JM, Siest G and Colin JN (1990) Phenobarbital inducible UDP-glucuronosyltransferase is responsible for glucuronidation of 3′-azido-3′-deoxythymidine: Characterization of the enzyme in human and rat liver microsomes. Arch Biochem Biophys 281:264-270.
17. Hoener BA (1994) Predicting the hepatic clearance of xenobiotics in humans from in vitro data. Biopharm Drug Dispos 12:295-304.
18. Howden CV, Birnie G and Brosie MJ (1988) Drug metabolism in liver disease. Pharmacol Ther 40:439-474.
19. Hoyumpa AM and Schenker S (1991) Is glucuronidation truly preserved in patients with liver disease? Hepatology 13:786-795.
20. James T, Bosch KS, Aronson DC and Houthooper JM (1990) Sirious red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver. Liver 10:1-5.
21. Lemoine A, Azoulay D, Gries JM, Dennison A, Castaing D, Fredj G, Debuire B, Maurel P, Bismuth H and Beaune P (1993) Relationship between graft cytochrome P450-3A content and early morbidity after liver transplantation. Transplantation 56:1410-1414.
22. Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, Belanger A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Luisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KE and Nebert DW (1997) The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269.
23. Magdalou J, Herber R, Bidault R and Siest G (1992) In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes. J Pharm Exp Ther 260:1166-1173.
24. Miners JO, Lillywhite KJ, Mattews AP, Jones ME and Birkett DJ (1988) Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphtol glucuronidation in human liver microsomes. Biochem Pharmacol 37:665-671.
25. Morgan DJ and Mc Lean AJ (1995) Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. Clin Pharmacokinet 29:370-391.
26. Patwardhan RV, Johnson RF, Huyumpa AM, Sheehann JJ, Desmond PV, Wilkinson GR and Branch RA (1981) Normal metabolism of morphine in cirrhosis. Gastroenterology 81:1006-1011.
27. Placidi I, Cretton EM, Placidi M and Sommadossi JP (1993) Reduction of 3′-azido-3′-deoxythymidine to 3′-amino-3′-deoxythymidine in human liver microsomes and its relationship to cytochrome P450. Clin Pharmacol Ther 54:168-176.
28. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649.
29. Rajaonarison JF, Lacarelle B, De Sousa G, Catalin J and Rhamani R (1991) In vitro glucuronidation of 3′-azido-3′deoxythimidine by human liver. Role of UDP-glucuronosyltransferase 2 forms. Drug Metab Dispos 19:809-815.
30. Rambeck B and Wolf P (1993) Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 25:433-443.
31. Ritschel WA, Brady ME, Tan HSI, Hoffman KA, Yiu IM and Grummich KW (1977) Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. Eur J Clin Pharmacol 12:57-61.
32. Rowland M, Benet LZ and Graham GG (1973) Clearance concept in pharmacokinetics. J Pharmacokinet Biopharm 1:123-136.
33. Saint-Pierre M and Pang S (1987) Determination of diazepam and its metabolites by high-performance liquid chromatography and thin-layer chromatography. J Chromatogr 421:291-307.
34. Shull HJR, Wilkinson GR, Johnson R and Schenker R (1976) Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 84:420-425.
35. Sonne J, Andreasen PB, Loft S, Dossing M and Andreasen F (1990) Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy. Hepatology 11:951-956.
36. Taburet AM, Naveau S, Zorza G, Colin JN, Delfraissy JF, Chaput JC and Singlas E (1990) Pharmacokinetics of zidovudine in patients with liver cirrhosis. Clin Pharmacol Ther 47:731-739.
37. Tan HSI, Ritschel WA and Sanders PR (1976) Determination of coumarin and umbelliferone mixtures in whole blood by spectrophotofluorometry. J Pharm Sci 65:30-32.
38. Teunissen MWE, Spoelstra P, Koch CW, Weeda B, Van Duyn W, Janssens AR and Breimer DD (1984) Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis. Br J Clin Pharmacol 18:707-715.
39. Witassek F, Bircher J, Huguenin P and Preisig R (1983) Abnormal glucuronidation of zomepirac in patients with cirrhosis of the liver. Hepatology 3:415-422.
40. Yuen WC and Peck AW (1988) Lamotrigine pharmacokinetics: Oral and i.v. infusion in man. Br J Clin Pharmacol 26:262.